comparemela.com

Latest Breaking News On - Uk gsk - Page 1 : comparemela.com

Moderna Stock Jumps on Surprise Profit, Sales Ahead of Expectations

Vaccine maker Moderna reported a profit of 55 cents a share on revenue of $2.8 billion in the December quarter, beating analysts’ expectations.

Jack dentonGetty imagesWall streetArticle normalBiotechnology servicesHealthcare life sciencesSpecialized drugs medicationsFinancial performanceSales figuresEarnings projectionsCorporate industrial newsPolitical general newsRespiratory tract diseasesMedical conditionsNovel coronavirusesInfectious diseases

U K stocks drop Tuesday

U.K. stocks dropped Tuesday, as the FTSE 100 Index closed down 0.81% at 7,512.28. Among FTSE 100 constituents, residential building construction company.

Barratt developmentsArticle normalMetal ore miningSilver ore miningBuilding constructionResidential building constructionCommercial bankingBasic materials resourcesBanking creditReal estate constructionFinancial servicesInternational banksMining quarryingNon ferrous metal ore miningCorporate industrial newsEquity markets

Moderna s RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer s

Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.

Josh nathan kazisEmma walmsleyTyler van burenVan burenJoseph preziosoMichael yeeCenters for diseaseGetty imagesDisease controlArticle normalBiotechnology servicesHealthcare life sciencesSpecialized drugs medicationsFinancial performanceCorporate industrial newsPolitical general news

AstraZeneca Stock Slips on Soft Earnings Report as Cancer Drug Sales Disappoint

The drugmaker AstraZeneca reported underwhelming earnings for its fourth quarter, as sales of a handful of its cancer medicines came in below investor.

United statesJosh nathan kazisDhiraj singh bloombergEli lillyAndrew berensPascal soriotDeutsche bank research emmanuel papadakisDeutsche bankDeutsche bank researchEmmanuel papadakisLeerink partnersArticle normalBiotechnology servicesCancer drugsHealthcare life sciencesSpecialized drugs medications

GSK lifts long-term outlook following launch of blockbuster vaccine in 2023

The FTSE-100 drugmaker predicted new drug and vaccine launches will see its annual sales hit £38 billion by 2031

City ofUnited kingdomEmma walmsleyDrug administrationArticle normalScientific research servicesHealth careBusiness consumer servicesSpecialized drugs medicationsMedical research servicesDrug discovery developmentHealthcare support servicesDiagnostic medical research servicesFinancial performanceSales figuresNew products services

vimarsana © 2020. All Rights Reserved.